Does GOLIMUMAB Cause Onychomadesis? 660 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 660 reports of Onychomadesis have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 1.0% of all adverse event reports for GOLIMUMAB.
660
Reports of Onychomadesis with GOLIMUMAB
1.0%
of all GOLIMUMAB reports
490
Deaths
567
Hospitalizations
How Dangerous Is Onychomadesis From GOLIMUMAB?
Of the 660 reports, 490 (74.2%) resulted in death, 567 (85.9%) required hospitalization, and 444 (67.3%) were considered life-threatening.
Is Onychomadesis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 660 reports have been filed with the FAERS database.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Off label use (8,764)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
What Other Drugs Cause Onychomadesis?
ADALIMUMAB (797)
METHOTREXATE (785)
RITUXIMAB (722)
TOCILIZUMAB (721)
ABATACEPT (703)
INFLIXIMAB (682)
SECUKINUMAB (678)
LEFLUNOMIDE (667)
HYDROXYCHLOROQUINE (660)
CERTOLIZUMAB PEGOL (654)
Which GOLIMUMAB Alternatives Have Lower Onychomadesis Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN